US Patent Issued to Five Prime Therapeutics on July 22 for "CD80 extracellular domain polypeptides and their use in cancer treatment" (California Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,365,719, issued on July 22, was assigned to Five Prime Therapeutics Inc. (Thousand Oaks, Calif.).

"CD80 extracellular domain polypeptides and their use in cancer treatment" was invented by Thomas Brennan (Thousand Oaks, Calif.), David Bellovin (Thousand Oaks, Calif.), Barbara Sennino (Thousand Oaks, Calif.) and David Busha (Thousand Oaks, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides antibodies and antigen-binding fragments thereof that specifically bind to human B7-H4 (and optionally cynomolgus monkey, mouse, and/or rat B7-H4) and compositions comprising such antibodies or antigen-binding fragments thereof. In a ...